{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:43:56Z","timestamp":1790685836502,"version":"4.1.0"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T00:00:00Z","timestamp":1499385600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s12016-017-8621-8","type":"journal-article","created":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T10:07:18Z","timestamp":1499422038000},"page":"114-130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":142,"title":["A Comprehensive Review of Neutrophilic Diseases"],"prefix":"10.1007","volume":"54","author":[{"given":"Angelo V.","family":"Marzano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wallach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Cugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,7]]},"reference":[{"key":"8621_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2165\/11595240-000000000-00000","volume":"13","author":"I Ahronowitz","year":"2012","unstructured":"Ahronowitz I, Harp J, Shinkai K (2012) Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol 13:191\u2013211. doi:\n10.2165\/11595240-000000000-00000","journal-title":"Am J Clin Dermatol"},{"key":"8621_CR2","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.jaad.2006.07.016","volume":"55","author":"D Wallach","year":"2006","unstructured":"Wallach D, Vignon-Pennamen MD (2006) From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research. J Am Acad Dermatol 55:1066\u20131071. doi:\n10.1016\/j.jaad.2006.07.016","journal-title":"J Am Acad Dermatol"},{"key":"8621_CR3","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.cell.2010.03.002","volume":"140","author":"DL Kastner","year":"2010","unstructured":"Kastner DL, Aksentijevich I, Goldbach-Mansky R (2010) Autoinflammatory disease reloaded: a clinical perspective. Cell 140:784\u2013790. doi:\n10.1016\/j.cell.2010.03.002","journal-title":"Cell"},{"key":"8621_CR4","doi-asserted-by":"publisher","unstructured":"Alavi A, French LE, Davis MD, Brassard A, Kirsner RS (2017) Pyoderma gangrenosum: an update on pathophysiology, diagnosis and treatment. Am J Clin Dermatol (in press). doi:\n10.1007\/s40257-017-0251-7","DOI":"10.1007\/s40257-017-0251-7"},{"key":"8621_CR5","doi-asserted-by":"publisher","unstructured":"Wallach D, Vignon-Pennamen MD (2015) Pyoderma gangrenosum and Sweet syndrome: the prototypic neutrophilic dermatoses. Br J Dermatol. doi:\n10.1111\/bjd.13955","DOI":"10.1111\/bjd.13955"},{"key":"8621_CR6","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.clindermatol.2013.11.004","volume":"32","author":"L Prat","year":"2014","unstructured":"Prat L, Bouaziz JD, Wallach D, Vignon-Pennamen MD, Bagot M (2014) Neutrophilic dermatoses as systemic diseases. Clin Dermatol 32:376\u2013388. doi:\n10.1016\/j.clindermatol.2013.11.004","journal-title":"Clin Dermatol"},{"key":"8621_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/01.MIB.0000436959.62286.f9","volume":"20","author":"AV Marzano","year":"2014","unstructured":"Marzano AV, Borghi A, Stadnicki A, Crosti C, Cugno M (2014) Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy. Inflamm Bowel Dis 20:213\u2013227. doi:\n10.1097\/01.MIB.0000436959.62286.f9","journal-title":"Inflamm Bowel Dis"},{"key":"8621_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0140-6736(97)10187-8","volume":"351","author":"JP Callen","year":"1998","unstructured":"Callen JP (1998) Pyoderma gangrenosum. Lancet 351:581\u2013585. doi:\n10.1016\/S0140-6736(97)10187-8","journal-title":"Lancet"},{"key":"8621_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3315\/jdcr.2009.1027","volume":"3","author":"N Jaimes-Lopez","year":"2009","unstructured":"Jaimes-Lopez N, Molina V, Arroyave JE, Vasquez LA, Ruiz AC, Castano R, Ruiz MH (2009) Development of pyoderma gangrenosum during therapy with infliximab. J Dermatol Case Rep 3:20\u201323. doi:\n10.3315\/jdcr.2009.1027","journal-title":"J Dermatol Case Rep"},{"key":"8621_CR10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1540-9740.2006.04575.x","volume":"5","author":"LE White","year":"2006","unstructured":"White LE, Villa MT, Petronic-Rosic V, Jiang J, Medenica MM (2006) Pyoderma gangrenosum related to a new granulocyte colony-stimulating factor. Skinmed 5:96\u201398","journal-title":"Skinmed"},{"key":"8621_CR11","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/j.1365-4632.2006.02749.x","volume":"45","author":"R Sagara","year":"2006","unstructured":"Sagara R, Kitami A, Nakada T, Iijima M (2006) Adverse reactions to gefitinib (Iressa): revealing sycosis- and pyoderma gangrenosum-like lesions. Int J Dermatol 45:1002\u20131003. doi:\n10.1111\/j.1365-4632.2006.02749.x","journal-title":"Int J Dermatol"},{"key":"8621_CR12","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/bjd.14691","volume":"175","author":"AV Marzano","year":"2016","unstructured":"Marzano AV, Borghi A, Meroni PL, Cugno M (2016) Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation. Br J Dermatol 175:882\u2013891. doi:\n10.1111\/bjd.14691","journal-title":"Br J Dermatol"},{"key":"8621_CR13","doi-asserted-by":"publisher","unstructured":"Cugno M, Borghi A, Marzano AV (2017) PAPA, PASH and PAPASH syndromes: pathophysiology, Presentation and Treatment. Am J Clin Dermatol. doi:\n10.1007\/s40257-017-0265-1","DOI":"10.1007\/s40257-017-0265-1"},{"key":"8621_CR14","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1038\/jid.2012.130","volume":"132","author":"SM Langan","year":"2012","unstructured":"Langan SM, Groves RW, Card TR, Gulliford MC (2012) Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol 132:2166\u20132170. doi:\n10.1038\/jid.2012.130","journal-title":"J Invest Dermatol"},{"key":"8621_CR15","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1365-2133.1997.tb01568.x","volume":"137","author":"P Driesch Von den","year":"1997","unstructured":"Von den Driesch P (1997) Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol 137:1000\u20131005","journal-title":"Br J Dermatol"},{"key":"8621_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3109\/09546631003686069","volume":"22","author":"AV Marzano","year":"2011","unstructured":"Marzano AV, Trevisan V, Lazzari R, Crosti C (2011) Pyoderma gangrenosum: study of 21 patients and proposal of a \u2018clinicotherapeutic\u2019 classification. J Dermatol Treat 22:254\u2013260. doi:\n10.3109\/09546631003686069","journal-title":"J Dermatol Treat"},{"key":"8621_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00403-009-1008-9","volume":"302","author":"A Varol","year":"2010","unstructured":"Varol A, Seifert O, Anderson CD (2010) The skin pathergy test: innately useful? Arch Dermatol Res 302:155\u2013168. doi:\n10.1007\/s00403-009-1008-9","journal-title":"Arch Dermatol Res"},{"key":"8621_CR18","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jaad.2015.06.054","volume":"73","author":"SN Tolkachjov","year":"2015","unstructured":"Tolkachjov SN, Fahy AS, Wetter DA, Brough KR, Bridges AG, Davis MD, El-Azhary RA, McEvoy MT, Camilleri MJ (2015) Postoperative pyoderma gangrenosum (PG): the Mayo Clinic experience of 20 years from 1994 through 2014. J Am Acad Dermatol 73:615\u2013622. doi:\n10.1016\/j.jaad.2015.06.054","journal-title":"J Am Acad Dermatol"},{"key":"8621_CR19","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1097\/SAP.0000000000000248","volume":"77","author":"SH Tuffaha","year":"2016","unstructured":"Tuffaha SH, Sarhane KA, Mundinger GS, Broyles JM, Reddy SK, Azoury SC, Seal S, Cooney DS, Bonawitz SC (2016) Pyoderma gangrenosum after breast surgery: diagnostic pearls and treatment recommendations based on a systematic literature review. Ann Plast Surg 77:e39\u2013e44. doi:\n10.1097\/SAP.0000000000000248","journal-title":"Ann Plast Surg"},{"key":"8621_CR20","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jaad.2016.05.044","volume":"75","author":"NS Barbosa","year":"2016","unstructured":"Barbosa NS, Tolkachjov SN, El-Azhary RA, Davis MD, Camilleri MJ, McEvoy MT, Bridges AG, Wetter DA (2016) Clinical features, causes, treatments, and outcomes of peristomal pyoderma gangrenosum (PPG) in 44 patients: the Mayo Clinic experience, 1996 through 2013. J Am Acad Dermatol 75:931\u2013939. doi:\n10.1016\/j.jaad.2016.05.044","journal-title":"J Am Acad Dermatol"},{"key":"8621_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s12016-012-8351-x","volume":"45","author":"AV Marzano","year":"2013","unstructured":"Marzano AV, Ishak RS, Saibeni S, Crosti C, Meroni PL, Cugno M (2013) Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet\u2019s syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol 45:202\u2013210. doi:\n10.1007\/s12016-012-8351-x","journal-title":"Clin Rev Allergy Immunol"},{"key":"8621_CR22","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/archderm.1972.01620150083026","volume":"106","author":"HO Perry","year":"1972","unstructured":"Perry HO, Winkelmann RK (1972) Bullous pyoderma gangrenosum and leukemia. Arch Dermatol 106:901\u2013905","journal-title":"Arch Dermatol"},{"key":"8621_CR23","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/0190-9622(92)70252-B","volume":"27","author":"KK Ho","year":"1992","unstructured":"Ho KK, Otridge BW, Vandenberg E, Powell FC (1992) Pyoderma gangrenosum, polycythemia rubra vera, and the development of leukemia. J Am Acad Dermatol 27:804\u2013808","journal-title":"J Am Acad Dermatol"},{"key":"8621_CR24","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1365-2230.2007.02607.x","volume":"33","author":"AV Marzano","year":"2008","unstructured":"Marzano AV, Tourlaki A, Alessi E, Caputo R (2008) Widespread idiopathic pyoderma gangrenosum evolved from ulcerative to vegetative type: a 10-year history with a recent response to infliximab. Clin Exp Dermatol 33:156\u2013159. doi:\n10.1111\/j.1365-2230.2007.02607.x","journal-title":"Clin Exp Dermatol"},{"key":"8621_CR25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00005792-200001000-00004","volume":"79","author":"ML Bennett","year":"2000","unstructured":"Bennett ML, Jackson JM, Jorizzo JL, Fleischer AB Jr, White WL, Callen JP (2000) Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore) 79:37\u201346","journal-title":"Medicine (Baltimore)"},{"key":"8621_CR26","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jama.284.12.1546","volume":"284","author":"AP Hughes","year":"2000","unstructured":"Hughes AP, Jackson JM, Callen JP (2000) Clinical features and treatment of peristomal pyoderma gangrenosum. JAMA 284:1546\u20131548","journal-title":"JAMA"},{"key":"8621_CR27","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/archderm.1930.01440160053009","volume":"22","author":"LA Brunsting","year":"1930","unstructured":"Brunsting LA, Goeckerman WH, O\u2019Leary PA (1930) Pyoderma (ecthyma) gangrenosum. Arch Dermatol Syphilol 22:655\u2013680","journal-title":"Arch Dermatol Syphilol"},{"key":"8621_CR28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0190-9622(96)90428-4","volume":"34","author":"FC Powell","year":"1996","unstructured":"Powell FC, Su WP, Perry HO (1996) Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 34:395\u2013409","journal-title":"J Am Acad Dermatol"},{"key":"8621_CR29","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/j.1468-3083.2009.03199.x","volume":"23","author":"E Ruocco","year":"2009","unstructured":"Ruocco E, Sangiuliano S, Gravina AG, Miranda A, Nicoletti G (2009) Pyoderma gangrenosum: an updated review. J Eur Acad Dermatol Venereol 23:1008\u20131017. doi:\n10.1111\/j.1468-3083.2009.03199.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8621_CR30","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1365-4632.2005.02591.x","volume":"44","author":"SM Langan","year":"2005","unstructured":"Langan SM, Powell FC (2005) Vegetative pyoderma gangrenosum: a report of two new cases and a review of the literature. Int J Dermatol 44:623\u2013629. doi:\n10.1111\/j.1365-4632.2005.02591.x","journal-title":"Int J Dermatol"},{"issue":"5 Suppl","key":"8621_CR31","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.1016\/j.jaad.2008.06.017","volume":"59","author":"KH Kitagawa","year":"2008","unstructured":"Kitagawa KH, Grassi M (2008) Primary pyoderma gangrenosum of the lungs. J Am Acad Dermatol 59(5 Suppl):S114\u2013S116. doi:\n10.1016\/j.jaad.2008.06.017","journal-title":"J Am Acad Dermatol"},{"key":"8621_CR32","first-page":"449","volume":"5","author":"MD Vignon-Pennamen","year":"1995","unstructured":"Vignon-Pennamen MD, Wallach D (1995) The neutrophilic disease: a review of extracutaneous neutrophilic manifestations. Eur J Dermatol 5:449\u2013455","journal-title":"Eur J Dermatol"},{"issue":"4","key":"8621_CR33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1684\/ejd.2012.1776","volume":"22","author":"AV Marzano","year":"2012","unstructured":"Marzano AV, Ishak RS, Lazzari R, Polloni I, Vettoretti S, Crosti C (2012) Vulvar pyoderma gangrenosum with renal involvement. Eur J Dermatol 22(4):537\u2013539. doi:\n10.1684\/ejd.2012.1776","journal-title":"Eur J Dermatol"},{"key":"8621_CR34","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/j.1365-4632.2004.02128.x","volume":"43","author":"WP Su","year":"2004","unstructured":"Su WP, Davis MD, Weenig RH, Powell FC, Perry HO (2004) Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol 43:790\u2013800. doi:\n10.1111\/j.1365-4632.2004.02128.x","journal-title":"Int J Dermatol"},{"key":"8621_CR35","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2340\/00015555-0346","volume":"88","author":"AV Marzano","year":"2008","unstructured":"Marzano AV, Trevisan V, Galloni C, Alessi E (2008) Fatal bullous pyoderma gangrenosum in a patient with Klinefelter\u2019s syndrome. Acta Derm Venereol 88:158\u2013159. doi:\n10.2340\/00015555-0346","journal-title":"Acta Derm Venereol"},{"key":"8621_CR36","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/j.1365-2133.2011.10565.x","volume":"165","author":"AM Binus","year":"2011","unstructured":"Binus AM, Qureshi AA, Li VW, Winterfield LS (2011) Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol 165:1244\u20131250. doi:\n10.1111\/j.1365-2133.2011.10565.x","journal-title":"Br J Dermatol"},{"key":"8621_CR37","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/0190-9622(93)70261-Q","volume":"29","author":"G Koester","year":"1993","unstructured":"Koester G, Tarnower A, Levisohn D, Burgdorf W (1993) Bullous pyoderma gangrenosum. J Am Acad Dermatol 29:875\u2013878","journal-title":"J Am Acad Dermatol"},{"key":"8621_CR38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2133.1964.tb14541.x","volume":"76","author":"RD Sweet","year":"1964","unstructured":"Sweet RD (1964) An acute febrile neutrophilic dermatosis. Br J Dermatol 76:349\u2013356","journal-title":"Br J Dermatol"},{"key":"8621_CR39","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jaad.2013.06.023","volume":"69","author":"NM Rochet","year":"2013","unstructured":"Rochet NM, Chavan RN, Cappel MA, Wada DA, Gibson LE (2013) Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients. J Am Acad Dermatol 69:557","journal-title":"J Am Acad Dermatol"},{"key":"8621_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1750-1172-2-34","volume":"2","author":"PR Cohen","year":"2007","unstructured":"Cohen PR (2007) Sweet\u2019s syndrome\u2014a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2:34. doi:\n10.1186\/1750-1172-2-34","journal-title":"Orphanet J Rare Dis"},{"key":"8621_CR41","first-page":"193","volume":"44","author":"P Driesch von den","year":"1989","unstructured":"von den Driesch P, Gomez RS, Kiesewetter F, Hornstein OP (1989) Sweet\u2019s syndrome: clinical spectrum and associated conditions. Cutis 44:193\u2013200","journal-title":"Cutis"},{"key":"8621_CR42","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-110-7-573_2","volume":"110","author":"PR Cohen","year":"1989","unstructured":"Cohen PR, Kurzrock R (1989) Diagnosing the Sweet syndrome. Ann Intern Med 110:573\u2013574","journal-title":"Ann Intern Med"},{"key":"8621_CR43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00007611-199402000-00009","volume":"87","author":"BW Boatman","year":"1994","unstructured":"Boatman BW, Taylor RC, Klein LE (1994) Sweet\u2019s syndrome in children. South Med J 87:193\u2013196","journal-title":"South Med J"},{"key":"8621_CR44","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0190-9622(00)90105-1","volume":"42","author":"S Sommer","year":"2000","unstructured":"Sommer S, Wilkinson SM, Merchant WJ, Goulden V (2000) Sweet\u2019s syndrome presenting as palmoplantar pustulosis. J Am Acad Dermatol 42:332\u2013334","journal-title":"J Am Acad Dermatol"},{"key":"8621_CR45","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jaad.2003.10.006","volume":"50","author":"C Sutra-Loubet","year":"2004","unstructured":"Sutra-Loubet C, Carlotti A, Guillemette J, Wallach D (2004) Neutrophilic lobular panniculitis. J Am Acad Dermatol 50:280\u2013285. doi:\n10.1016\/j.jaad.2003.10.006","journal-title":"J Am Acad Dermatol"},{"key":"8621_CR46","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jaad.2012.12.954","volume":"68","author":"MP Chan","year":"2013","unstructured":"Chan MP, Duncan LM, Nazarian RM (2013) Subcutaneous Sweet syndrome in the setting of myeloid disorders: a case series and review of the literature. J Am Acad Dermatol 68:1006\u20131015. doi:\n10.1016\/j.jaad.2012.12.954","journal-title":"J Am Acad Dermatol"},{"key":"8621_CR47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13760-016-0695-1","volume":"117","author":"F Drago","year":"2017","unstructured":"Drago F, Ciccarese G, Agnoletti AF, Sarocchi F, Parodi A (2017) Neuro sweet syndrome: a systematic review. A rare complication of Sweet syndrome. Acta Neurol Belg 117:33\u201342","journal-title":"Acta Neurol Belg"},{"key":"8621_CR48","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0190-9622(94)70215-2","volume":"31","author":"P Driesch von den","year":"1994","unstructured":"von den Driesch P (1994) Sweet\u2019s syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 31:535\u2013556","journal-title":"J Am Acad Dermatol"},{"key":"8621_CR49","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0190-9622(90)70250-L","volume":"23","author":"D Kemmett","year":"1990","unstructured":"Kemmett D, Hunter JAA (1990) Sweet\u2019s syndrome: a clinicopathologic review of twenty-nine cases. J Am Acad Dermatol 23:503\u2013507","journal-title":"J Am Acad Dermatol"},{"key":"8621_CR50","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-4362.1993.tb04265.x","volume":"32","author":"D Sitjas","year":"1993","unstructured":"Sitjas D, Cuatrecasas M, De Moragas JM (1993) Acute febrile neutrophilic dermatosis (Sweet\u2019s syndrome). Int J Dermatol 32:261\u2013268","journal-title":"Int J Dermatol"},{"key":"8621_CR51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0022-3476(83)80529-0","volume":"102","author":"AJ Muster","year":"1983","unstructured":"Muster AJ, Bharati S, Herman JJ, Esterly NB, Gonzales-Crussi F, Holbrook KA (1983) Fatal cardiovascular disease and cutis laxa following acute febrile neutrophilic dermatosis. J Pediatr 102:243\u2013248","journal-title":"J Pediatr"},{"key":"8621_CR52","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0046-8177(95)90177-9","volume":"26","author":"D Attias","year":"1995","unstructured":"Attias D, Laor R, Zuckermann E, Naschitz JE, Luria M, Misselevitch I, Boss JH (1995) Acute neutrophilic myositis in Sweet\u2019s syndrome: late phase transformation into fibrosing myositis and panniculitis. Hum Pathol 26:687\u2013690","journal-title":"Hum Pathol"},{"key":"8621_CR53","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0190-9622(96)90080-8","volume":"34","author":"DC Walker","year":"1996","unstructured":"Walker DC, Cohen PR (1996) Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug induced Sweet\u2019s syndrome. J Am Acad Dermatol 34:918\u2013923","journal-title":"J Am Acad Dermatol"},{"key":"8621_CR54","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000247736","volume":"182","author":"H Mensing","year":"1991","unstructured":"Mensing H, Kowalzick L (1991) Acute febrile neutrophilic dermatosis (Sweet\u2019s syndrome) caused by minocycline. Dermatologica 182:43\u201346","journal-title":"Dermatologica"},{"key":"8621_CR55","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1345\/aph.1H563","volume":"41","author":"DF Thompson","year":"2007","unstructured":"Thompson DF, Montarella KE (2007) Drug-induced Sweet\u2019s syndrome. Ann Pharmacother 41:802\u2013811. doi:\n10.1345\/aph.1H563","journal-title":"Ann Pharmacother"},{"key":"8621_CR56","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000246219","volume":"193","author":"AV Marzano","year":"1996","unstructured":"Marzano AV, Capsoni F, Berti E, Gasparini G, Bottelli S, Caputo R (1996) Amicrobial pustular dermatosis of cutaneous folds associated with autoimmune disorders: a new entity? Dermatology 193:88\u201393","journal-title":"Dermatology"},{"key":"8621_CR57","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/096120339700600607","volume":"6","author":"S Lagrange","year":"1997","unstructured":"Lagrange S, Chosidow O, Flette JC, Wechsler B, Godeau P, Frances C (1997) A peculiar form of amicrobial pustulosis of the folds associated with systemic lupus erythematosus and other autoimmune diseases. Lupus 6:514\u2013520","journal-title":"Lupus"},{"key":"8621_CR58","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000018041","volume":"197","author":"MP Stefanidou","year":"1998","unstructured":"Stefanidou MP, Kanavaros PE, Stefanaki KS, Tosca AD (1998) Amicrobial pustulosis of the folds: a cutaneous manifestation associated with connective tissue disease. Dermatology 197:394\u2013396","journal-title":"Dermatology"},{"key":"8621_CR59","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1046\/j.1365-2230.2002.01035.x","volume":"27","author":"M Kuyama","year":"2002","unstructured":"Kuyama M, Fujimoto W, Kambara H, Egusa M, Saitoh M, Yamasaki O, Maehara K, Ohara A, Arata J, Iwatsuki K (2002) Amicrobial pustular dermatosis in two patients with immunological abnormalities. Clin Exp Dermatol 27:286\u2013289","journal-title":"Clin Exp Dermatol"},{"key":"8621_CR60","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1159\/000088508","volume":"211","author":"K Kerl","year":"2005","unstructured":"Kerl K, Masouy\u00e9 I, Lesavre P, Saurat JH, Borradori L (2005) A case of amicrobial pustulosis of the folds associated with neutrophilic gastrointestinal involvement in systemic lupus erythematosus. Dermatology 211:356\u2013359. doi:\n10.1159\/000088508","journal-title":"Dermatology"},{"key":"8621_CR61","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1159\/000113942","volume":"216","author":"AV Marzano","year":"2008","unstructured":"Marzano AV, Ramoni S, Caputo R (2008) Amicrobial pustulosis of the folds. Report of 6 cases and a literature review. Dermatology 216:305\u2013311. doi:\n10.1159\/000113942","journal-title":"Dermatology"},{"key":"8621_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000343595","volume":"226","author":"S M\u00e9ndez-Flores","year":"2013","unstructured":"M\u00e9ndez-Flores S, Charli-Joseph Y, Saeb-Lima M, Orozco-Topete R, Fern\u00e1ndez S\u00e1nchez M (2013) Amicrobial pustulosis of the folds associated with autoimmune disorders: systemic lupus erythematosus case series and first report on the association with autoimmune hepatitis. Dermatology 226:1\u20134. doi:\n10.1159\/000343595","journal-title":"Dermatology"},{"key":"8621_CR63","unstructured":"Crickx B, Diego ML, Guillevin L, Picard C, Grossins M, Bela\u00efch S (1991) Pustulose amicrobienne et lupus \u00e9ryth\u00e9mateux syst\u00e9mique. Communication n\u00b0 11 (letter). Journ\u00e9es Dermatologiques de Paris Par\u00eds, March 1991"},{"key":"8621_CR64","first-page":"824","volume":"118","author":"P Oberlin","year":"1991","unstructured":"Oberlin P, Bagot M, Perrussel M, Leteinturier F, Wechsler J, Revuz J (1991) Pustulose amicrobienne et lupus \u00e9ryth\u00e9mateux syst\u00e9mique. Ann Dermatol V\u00e9n\u00e9r\u00e9ol 118:824\u2013825","journal-title":"Ann Dermatol V\u00e9n\u00e9r\u00e9ol"},{"key":"8621_CR65","first-page":"779","volume":"120","author":"PH Saiag","year":"1993","unstructured":"Saiag PH, Blanc F, Marinho E, De La Blanchardi\u00e8re A, Leconte I, Cocheton JJ, Tulliez M (1993) Pustulose amicrobienne et lupus \u00e9ryth\u00e9mateux syst\u00e9mique: un cas. Ann Dermatol V\u00e9n\u00e9r\u00e9ol 120:779\u2013781","journal-title":"Ann Dermatol V\u00e9n\u00e9r\u00e9ol"},{"key":"8621_CR66","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1046\/j.1365-2133.2000.03907.x","volume":"143","author":"N B\u00e9n\u00e9ton","year":"2000","unstructured":"B\u00e9n\u00e9ton N, Wolkenstein P, Bagot M, Cosnes A, Wechsler J, Roujeau JC, Revuz J (2000) Amicrobial pustulosis associated with autoimmune diseases: healing with zinc supplementation. Br J Dermatol 143:1306\u20131310","journal-title":"Br J Dermatol"},{"key":"8621_CR67","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1684\/ejd.2011.1406","volume":"21","author":"A Claeys","year":"2011","unstructured":"Claeys A, Bessis D, Cheikhrouhou H, Pouaha J, Cuny JF, Truchetet F (2011) Amicrobial pustulosis of the folds revealing asymptomatic autoimmune thyroiditis. Eur J Dermatol 21:641\u2013642. doi:\n10.1684\/ejd.2011.1406","journal-title":"Eur J Dermatol"},{"key":"8621_CR68","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1365-2230.2011.04262.x","volume":"37","author":"YL Lim","year":"2012","unstructured":"Lim YL, Ng SK, Lian TY (2012) Amicrobial pustulosis associated with autoimmune disease in a patient with Sj\u00f6gren syndrome and IgA nephropathy. Clin Exp Dermatol 37:374\u2013378. doi:\n10.1111\/j.1365-2230.2011.04262.x","journal-title":"Clin Exp Dermatol"},{"key":"8621_CR69","doi-asserted-by":"publisher","first-page":"e2301","DOI":"10.1097\/MD.0000000000002301","volume":"94","author":"AV Marzano","year":"2015","unstructured":"Marzano AV, Tavecchio S, Berti E, Gelmetti C, Cugno M (2015) Cytokine and chemokine profile in amicrobial pustulosis of the folds: evidence for autoinflammation. Medicine (Baltimore) 94:e2301. doi:\n10.1097\/MD.0000000000002301","journal-title":"Medicine (Baltimore)"},{"key":"8621_CR70","doi-asserted-by":"publisher","first-page":"e1818","DOI":"10.1097\/MD.0000000000001818","volume":"94","author":"AV Marzano","year":"2015","unstructured":"Marzano AV, Tavecchio S, Berti E, Gelmetti C, Cugno M (2015) Paradoxical autoinflammatory skin reaction to tumor necrosis factor alpha blockers manifesting as amicrobial pustulosis of the folds in patients with inflammatory bowel diseases. Medicine (Baltimore) 94:e1818. doi:\n10.1097\/MD.0000000000001818","journal-title":"Medicine (Baltimore)"},{"key":"8621_CR71","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000247696","volume":"183","author":"MD Vignon-Pennamen","year":"1991","unstructured":"Vignon-Pennamen MD, Wallach D (1991) Cutaneous manifestations of neutrophilic disease. Dermatologica 183:255\u2013264","journal-title":"Dermatologica"},{"key":"8621_CR72","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jaad.2007.05.023","volume":"57","author":"K Natsuga","year":"2007","unstructured":"Natsuga K, Sawamura D, Homma E, Nomura T, Abe M, Muramatsu R, Mochizuki T, Koike T, Shimizu H (2007) Amicrobial pustulosis associated with IgA nephropathy and Sj\u00f6gren\u2019s syndrome. J Am Acad Dermatol 57:523\u2013526. doi:\n10.1016\/j.jaad.2007.05.023","journal-title":"J Am Acad Dermatol"},{"key":"8621_CR73","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s001050050800","volume":"49","author":"O Hoch","year":"1998","unstructured":"Hoch O, Herbst RA, Gutzmer R, Kiehl P, Kapp A, Weiss J (1998) Amicrobial intertriginous pustulosis in autoimmune disease: a new entity? Hautarzt 49:634\u2013640","journal-title":"Hautarzt"},{"key":"8621_CR74","doi-asserted-by":"publisher","first-page":"e561","DOI":"10.1111\/j.1365-2230.2009.03370.x","volume":"34","author":"N L\u00f3pez-Navarro","year":"2009","unstructured":"L\u00f3pez-Navarro N, Alcaide A, Gallego E, Herrera-Acosta E, Gallardo M, Bosch RJ, Herrera E (2009) Amicrobial pustulosis of the folds associated with Hashimoto\u2019s thyroiditis. Clin Exp Dermatol 34:e561\u2013e563. doi:\n10.1111\/j.1365-2230.2009.03370.x","journal-title":"Clin Exp Dermatol"},{"key":"8621_CR75","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1159\/000329428","volume":"222","author":"HY Lee","year":"2011","unstructured":"Lee HY, Pelivani N, Beltraminelli H, Hegyi I, Yawalkar N, Borradori L (2011) Amicrobial pustulosis-like rash in a patient with Crohn\u2019s disease under anti-TNF-alpha blocker. Dermatology 222:304\u2013310. doi:\n10.1159\/000329428","journal-title":"Dermatology"},{"key":"8621_CR76","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2165\/00128071-200607060-00005","volume":"7","author":"S Boms","year":"2006","unstructured":"Boms S, Gambichler T (2006) Review of literature on amicrobial pustulosis of the folds associated with autoimmune disorders. Am J Clin Dermatol 7:369\u2013374","journal-title":"Am J Clin Dermatol"},{"key":"8621_CR77","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.det.2013.04.001","volume":"31","author":"HB Naik","year":"2013","unstructured":"Naik HB, Cowen EW (2013) Autoinflammatory pustular neutrophilic diseases. Dermatol Clin 31:405\u2013425. doi:\n10.1016\/j.det.2013.04.001","journal-title":"Dermatol Clin"},{"key":"8621_CR78","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/hmg\/11.8.961","volume":"11","author":"CA Wise","year":"2002","unstructured":"Wise CA, Gillum JD, Seidman CE, Lindor NM, Veile R, Bashiardes S, Lovett M (2002) Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet 11:961\u2013969","journal-title":"Hum Mol Genet"},{"key":"8621_CR79","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2174\/138920210793175921","volume":"11","author":"EJ Smith","year":"2010","unstructured":"Smith EJ, Allantaz F, Bennett L, Zhang D, Gao X, Wood G, Kastner DL, Punaro M, Aksentijevich I, Pascual V, Wise CA (2010) Clinical, molecular, and genetic characteristics of PAPA syndrome: a review. Curr Genomics 11:519\u2013527. doi:\n10.2174\/138920210793175921","journal-title":"Curr Genomics"},{"key":"8621_CR80","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/jid.2013.438","volume":"134","author":"M Kistowska","year":"2014","unstructured":"Kistowska M, Gehrke S, Jankovic D, Kerl K, Fettelschoss A, Feldmeyer L, Fenini G, Kolios A, Navarini A, Ganceviciene R, Schauber J, Contassot E, French LE (2014) IL-1\u03b2 drives inflammatory responses to Propionibacterium acnes in vitro and in vivo. J Invest Dermatol 134:677\u2013685. doi:\n10.1038\/jid.2013.438","journal-title":"J Invest Dermatol"},{"key":"8621_CR81","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/jid.2013.309","volume":"134","author":"M Qin","year":"2014","unstructured":"Qin M, Pirouz A, Kim MH, Krutzik SR, Garb\u00e1n HJ, Kim J (2014) Propionibacterium acnes induces IL-1\u03b2 secretion via the NLRP3 inflammasome in human monocytes. J Invest Dermatol 134:381\u2013388. doi:\n10.1038\/jid.2013.309","journal-title":"J Invest Dermatol"},{"key":"8621_CR82","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1038\/jid.2014.221","volume":"134","author":"ZJ Li","year":"2014","unstructured":"Li ZJ, Choi DK, Sohn KC, Seo MS, Lee HE, Lee Y, Seo YJ, Lee YH, Shi G, Zouboulis CC, Kim CD, Lee JH, Im M (2014) Propionibacterium acnes activates the NLRP3 inflammasome in human sebocytes. J Invest Dermatol 134:2747\u20132756. doi:\n10.1038\/jid.2014.221","journal-title":"J Invest Dermatol"},{"key":"8621_CR83","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jaad.2010.12.025","volume":"66","author":"M Braun-Falco","year":"2012","unstructured":"Braun-Falco M, Kovnerystyy O, Lohse P, Ruzicka T (2012) Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)\u2014a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol 66:409\u2013415. doi:\n10.1016\/j.jaad.2010.12.025","journal-title":"J Am Acad Dermatol"},{"key":"8621_CR84","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1097\/MD.0000000000000187","volume":"93","author":"AV Marzano","year":"2014","unstructured":"Marzano AV, Ceccherini I, Gattorno M, Fanoni D, Caroli F, Rusmini M, Grossi A, De Simone C, Borghi OM, Meroni PL, Crosti C, Cugno M (2014) Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases. Medicine (Baltimore) 93:e187. doi:\n10.1097\/MD.0000000000000187","journal-title":"Medicine (Baltimore)"},{"key":"8621_CR85","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.jid.2016.05.102","volume":"136","author":"HH Zee van der","year":"2016","unstructured":"van der Zee HH, Horvath B, Jemec GB, Prens EP (2016) The association between hidradenitis suppurativa and Crohn\u2019s disease: in search of the missing pathogenic link. J Invest Dermatol 136:1747\u20131748. doi:\n10.1016\/j.jid.2016.05.102","journal-title":"J Invest Dermatol"},{"key":"8621_CR86","doi-asserted-by":"publisher","unstructured":"Damiani G, Della Valle V, Iannone M, Dini V, Marzano AV (2016) Autoinflammatory Disease Damage Index (ADDI): a possible newborn also in hidradenitis suppurativa daily practice. Ann Rheum Dis (in press). doi:\n10.1136\/annrheumdis-2016-210901","DOI":"10.1136\/annrheumdis-2016-210901"},{"key":"8621_CR87","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/bjd.14364","volume":"174","author":"AV Marzano","year":"2016","unstructured":"Marzano AV (2016) Hidradenitis suppurativa, neutrophilic dermatoses and autoinflammation: what\u2019s the link? Br J Dermatol 174:482\u2013483. doi:\n10.1111\/bjd.14364","journal-title":"Br J Dermatol"},{"key":"8621_CR88","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMcp1014163","volume":"366","author":"GB Jemec","year":"2012","unstructured":"Jemec GB (2012) Clinical practice. Hidradenitis suppurativa. N Engl J Med 366:158\u2013164. doi:\n10.1056\/NEJMcp1014163","journal-title":"N Engl J Med"},{"key":"8621_CR89","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.clindermatol.2013.11.006","volume":"32","author":"C Dessinioti","year":"2014","unstructured":"Dessinioti C, Katsambas A, Antoniou C (2014) Hidradenitis suppurativa (acne inversa) as a systemic disease. Clin Dermatol 32:397\u2013408. doi:\n10.1016\/j.clindermatol.2013.11.006","journal-title":"Clin Dermatol"},{"key":"8621_CR90","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jdv.12966","volume":"29","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juh\u00e1sz I, Lapins J, Matusiak L, Prens EP, Revuz J, Schneider-Burrus S, Szepietowski JC, van der Zee HH, Jemec GB (2015) European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa. J Eur Acad Dermatol Venereol 29:619\u2013644. doi:\n10.1111\/jdv.12966","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8621_CR91","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/bjd.13668","volume":"173","author":"S Duchatelet","year":"2015","unstructured":"Duchatelet S, Miskinyte S, Join-Lambert O, Ungeheuer MN, Franc\u00e8s C, Nassif A, Hovnanian A (2015) First nicastrin mutation in PASH (pyoderma gangrenosum, acne and suppurative hidradenitis) syndrome. Br J Dermatol 173:610\u2013612. doi:\n10.1111\/bjd.13668","journal-title":"Br J Dermatol"},{"key":"8621_CR92","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/bjd.14383","volume":"175","author":"X Calder\u00f3n-Castrat","year":"2016","unstructured":"Calder\u00f3n-Castrat X, Bancalari-Diaz D, Rom\u00e1n-Curto C, Romo-Melgar A, Amor\u00f3s-Cerd\u00e1n D, Alcaraz-Mas LA, Fern\u00e1ndez-L\u00f3pez E, Ca\u00f1ueto J (2016) PSTPIP1 gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome. Br J Dermatol 175:194\u2013198. doi:\n10.1111\/bjd.14383","journal-title":"Br J Dermatol"},{"key":"8621_CR93","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/RHU.0b013e318278b84c","volume":"18","author":"V Bruzzese","year":"2012","unstructured":"Bruzzese V (2012) Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor \u03b1 therapy. J Clin Rheumatol 18:413\u2013415. doi:\n10.1097\/RHU.0b013e318278b84c","journal-title":"J Clin Rheumatol"},{"key":"8621_CR94","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jamadermatol.2013.2907","volume":"149","author":"AV Marzano","year":"2013","unstructured":"Marzano AV, Trevisan V, Gattorno M, Ceccherini I, De Simone C, Crosti C (2013) Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene. JAMA Dermatol 149:762\u2013764. doi:\n10.1001\/jamadermatol.2013.2907","journal-title":"JAMA Dermatol"},{"key":"8621_CR95","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/jdv.12631","volume":"30","author":"N Garzorz","year":"2016","unstructured":"Garzorz N, Papanagiotou V, Atenhan A, Andres C, Eyerich S, Eyerich K, Ring J, Brockow K (2016) Pyoderma gangrenosum, acne, psoriasis, arthritis and suppurative hidradenitis (PAPASH)-syndrome: a new entity within the spectrum of autoinflammatory syndromes? J Eur Acad Dermatol Venereol 30:141\u2013143. doi:\n10.1111\/jdv.12631","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8621_CR96","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1016\/j.jaad.2014.10.002","volume":"72","author":"R Saraceno","year":"2015","unstructured":"Saraceno R, Babino G, Chiricozzi A, Zangrilli A, Chimenti S (2015) PsAPASH: a new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition. J Am Acad Dermatol 72:e42\u2013e44. doi:\n10.1016\/j.jaad.2014.10.002","journal-title":"J Am Acad Dermatol"},{"key":"8621_CR97","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00281-015-0549-6","volume":"38","author":"AA Navarini","year":"2016","unstructured":"Navarini AA, Satoh TK, French LE (2016) Neutrophilic dermatoses and autoinflammatory diseases with skin involvement\u2013innate immune disorders. Semin Immunopathol 38:45\u201356. doi:\n10.1007\/s00281-015-0549-6","journal-title":"Semin Immunopathol"},{"key":"8621_CR98","doi-asserted-by":"publisher","unstructured":"Satoh TK, Mellett M, Contassot E, French LE (2016) Are neutrophilic dermatoses autoinflammatory disorders? Br J Dermatol (in press). doi:\n10.1111\/bjd.15105","DOI":"10.1111\/bjd.15105"},{"key":"8621_CR99","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","volume":"97","author":"MF McDermott","year":"1999","unstructured":"McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M, Mansfield E, Gadina M, Karenko L, Pettersson T, McCarthy J, Frucht DM, Aringer M, Torosyan Y, Teppo AM, Wilson M, Karaarslan HM, Wan Y, Todd I, Wood G, Schlimgen R, Kumarajeewa TR, Cooper SM, Vella JP, Amos CI, Mulley J, Quane KA, Molloy MG, Ranki A, Powell RJ, Hitman GA, O\u2019Shea JJ, Kastner DL (1999) Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97:133\u2013144","journal-title":"Cell"},{"key":"8621_CR100","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","volume":"117","author":"CA Dinarello","year":"2011","unstructured":"Dinarello CA (2011) Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117:3720\u20133732. doi:\n10.1182\/blood-2010-07-273417","journal-title":"Blood"},{"key":"8621_CR101","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-pathol-012414-040431","volume":"10","author":"L Broderick","year":"2015","unstructured":"Broderick L, De Nardo D, Franklin BS, Hoffman HM, Latz E (2015) The inflammasomes and autoinflammatory syndromes. Annu Rev Pathol 10:395\u2013424. doi:\n10.1146\/annurev-pathol-012414-040431","journal-title":"Annu Rev Pathol"},{"key":"8621_CR102","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng756","volume":"29","author":"HM Hoffman","year":"2001","unstructured":"Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD (2001) Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 29:301\u2013305","journal-title":"Nat Genet"},{"key":"8621_CR103","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10:417\u2013426","journal-title":"Mol Cell"},{"key":"8621_CR104","doi-asserted-by":"publisher","first-page":"437","DOI":"10.4103\/2319-4170.104408","volume":"35","author":"N Sa\u00efd-Sadier","year":"2012","unstructured":"Sa\u00efd-Sadier N, Ojcius DM (2012) Alarmins, inflammasomes and immunity. Biom J 35:437\u2013449. doi:\n10.4103\/2319-4170.104408","journal-title":"Biom J"},{"key":"8621_CR105","doi-asserted-by":"publisher","unstructured":"Marzano AV, Damiani G, Ceccherini I, Berti E, Gattorno M, Cugno M (2016) Autoinflammation in pyoderma gangrenosum and its syndromic form PASH. Br J Dermatol. doi:\n10.1111\/bjd.15226","DOI":"10.1111\/bjd.15226"},{"key":"8621_CR106","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/rheumatology\/kei178","volume":"45","author":"B Tallon","year":"2006","unstructured":"Tallon B, Corkill M (2006) Peculiarities of PAPA syndrome. Rheumatology 45:1140\u20131143. doi:\n10.1093\/rheumatology\/kei178","journal-title":"Rheumatology"},{"key":"8621_CR107","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1086\/302866","volume":"66","author":"HB Yeon","year":"2000","unstructured":"Yeon HB, Lindor NM, Seidman JG, Seidman CE (2000) Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q. Am J Hum Genet 66:1443\u20131448","journal-title":"Am J Hum Genet"},{"key":"8621_CR108","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.clim.2013.01.006","volume":"147","author":"MC Heymann","year":"2013","unstructured":"Heymann MC, Rosen-Wolff A (2013) Contribution of the inflammasomes to autoinflammatory diseases and recent mouse models as research tools. Clin Immunol 147:175\u2013184. doi:\n10.1016\/j.clim.2013.01.006","journal-title":"Clin Immunol"},{"key":"8621_CR109","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10354-014-0285-x","volume":"164","author":"U Wollina","year":"2014","unstructured":"Wollina U, Tchernev G (2014) Pyoderma gangrenosum: pathogenetic oriented treatment approaches. Wien Med Wochenschr 164:263\u2013273. doi:\n10.1007\/s10354-014-0285-x","journal-title":"Wien Med Wochenschr"},{"key":"8621_CR110","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/BOR.0b013e328341152f","volume":"23","author":"U Wollina","year":"2011","unstructured":"Wollina U, Haroske G (2011) Pyoderma gangraenosum. Curr Opin Rheumatol 23:50\u201356. doi:\n10.1097\/BOR.0b013e328341152f","journal-title":"Curr Opin Rheumatol"},{"key":"8621_CR111","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1365-2230.2012.04375.x","volume":"38","author":"JA Palanivel","year":"2013","unstructured":"Palanivel JA, Macbeth AE, Levell NJ (2013) Pyoderma gangrenosum in association with Janus kinase 2 (JAK2V617F) mutation. Clin Exp Dermatol 38:44\u201346. doi:\n10.1111\/j.1365-2230.2012.04375.x","journal-title":"Clin Exp Dermatol"},{"key":"8621_CR112","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/bjd.13493","volume":"172","author":"EM DeFilippis","year":"2015","unstructured":"DeFilippis EM, Feldman SR, Huang WW (2015) The genetics of pyoderma gangrenosum and implications for treatment: a systematic review. Br J Dermatol 172:1487\u20131497. doi:\n10.1111\/bjd.13493","journal-title":"Br J Dermatol"},{"key":"8621_CR113","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1365-2249.2010.04201.x","volume":"162","author":"AV Marzano","year":"2010","unstructured":"Marzano AV, Cugno M, Trevisan V, Fanoni D, Venegoni L, Berti E, Crosti C (2010) Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol 162:100\u2013107. doi:\n10.1111\/j.1365-2249.2010.04201.x","journal-title":"Clin Exp Immunol"},{"key":"8621_CR114","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/cei.12394","volume":"178","author":"AV Marzano","year":"2014","unstructured":"Marzano AV, Fanoni D, Antiga E, Quaglino P, Caproni M, Crosti C, Meroni PL, Cugno M (2014) Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet\u2019s syndrome. Clin Exp Immunol 178:48\u201356. doi:\n10.1111\/cei.12394","journal-title":"Clin Exp Immunol"},{"key":"8621_CR115","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/bjd.14214","volume":"174","author":"AL Lima","year":"2016","unstructured":"Lima AL, Karl I, Giner T, Poppe H, Schmidt M, Presser D, Goebeler M, Bauer B (2016) Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa. Br J Dermatol 174:514\u2013521. doi:\n10.1111\/bjd.14214","journal-title":"Br J Dermatol"},{"key":"8621_CR116","doi-asserted-by":"publisher","first-page":"13501","DOI":"10.1073\/pnas.2135380100","volume":"100","author":"NG Shoham","year":"2003","unstructured":"Shoham NG, Centola M, Mansfield E, Hull KM, Wood G, Wise CA, Kastner DL (2003) Pyrin binds the PSTPIP1\/CD2BP1 protein, defining familial Mediterranean fever andPAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci U S A 100:13501\u201313506. doi:\n10.1073\/pnas.2135380100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8621_CR117","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jaad.2015.06.021","volume":"73","author":"SF Braswell","year":"2015","unstructured":"Braswell SF, Kostopoulos TC, Ortega-Loayza AG (2015) Pathophysiology of pyoderma gangrenosum (PG): an updated review. J Am Acad Dermatol 73:691\u2013698. doi:\n10.1016\/j.jaad.2015.06.021","journal-title":"J Am Acad Dermatol"},{"key":"8621_CR118","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/bjd.13670","volume":"173","author":"M Caproni","year":"2015","unstructured":"Caproni M, Antiga E, Volpi W, Verdelli A, Venegoni L, Quaglino P, Fabbri P, Marzano AV (2015) The Treg\/Th17 cell ratio is reduced in the skin lesions of patients with pyoderma gangrenosum. Br J Dermatol 173:275\u2013278. doi:\n10.1111\/bjd.13670","journal-title":"Br J Dermatol"},{"key":"8621_CR119","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1016\/j.jaad.2013.12.041","volume":"71","author":"E Amazan","year":"2014","unstructured":"Amazan E, Ezzedine K, Mossalayi MD, Taieb A, Boniface K, Seneschal J (2014) Expression of interleukin-1 alpha in amicrobial pustulosis of the skin folds with complete response to anakinra. J Am Acad Dermatol 71:e53\u2013e56. doi:\n10.1016\/j.jaad.2013.12.041","journal-title":"J Am Acad Dermatol"},{"key":"8621_CR120","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1177\/039463201102400218","volume":"24","author":"AV Marzano","year":"2011","unstructured":"Marzano AV, Cugno M, Trevisan V, Lazzari R, Fanoni D, Berti E, Crosti C (2011) Inflammatory cells, cytokines and matrix metalloproteinases in amicrobialpustulosis of the folds and other neutrophilic dermatoses. Int J Immunopathol Pharmacol 24:451\u2013460. doi:\n10.1177\/039463201102400218","journal-title":"Int J Immunopathol Pharmacol"},{"key":"8621_CR121","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1136\/gut.2005.074815","volume":"55","author":"TN Brooklyn","year":"2006","unstructured":"Brooklyn TN, Dunnill MG, Shetty A, Bowden JJ, Williams JD, Griffiths CE, Forbes A, Greenwood R, Probert CS (2006) Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut 55:505\u2013509. doi:\n10.1136\/gut.2005.074815","journal-title":"Gut"},{"key":"8621_CR122","doi-asserted-by":"publisher","first-page":"h2958","DOI":"10.1136\/bmj.h2958","volume":"350","author":"AD Ormerod","year":"2015","unstructured":"Ormerod AD, Thomas KS, Craig FE, Mitchell E, Greenlaw N, Norrie J, Mason JM, Walton S, Johnston GA, Williams HC, UK Dermatology Clinical Trials Network\u2019s STOP GAP Team (2015) Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial. BMJ 350:h2958. doi:\n10.1136\/bmj.h2958","journal-title":"BMJ"},{"key":"8621_CR123","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jaad.2004.10.006","volume":"53","author":"J Reichrath","year":"2005","unstructured":"Reichrath J, Bens G, Bonowitz A, Tilgen W (2005) Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol 53:273\u2013283. doi:\n10.1016\/j.jaad.2004.10.006","journal-title":"J Am Acad Dermatol"},{"key":"8621_CR124","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jaad.2009.05.030","volume":"62","author":"J Miller","year":"2010","unstructured":"Miller J, Yentzer BA, Clark A, Jorizzo JL, Feldman SR (2010) Pyoderma gangrenosum: a review and update on new therapies. J Am Acad Dermatol 62:646\u2013654. doi:\n10.1016\/j.jaad.2009.05.030","journal-title":"J Am Acad Dermatol"},{"key":"8621_CR125","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/MOH.0000000000000100","volume":"22","author":"D Maalouf","year":"2015","unstructured":"Maalouf D, Battistella M, Bouaziz JD (2015) Neutrophilic dermatosis: disease mechanism and treatment. Curr Opin Hematol 22:23\u201329. doi:\n10.1097\/MOH.0000000000000100","journal-title":"Curr Opin Hematol"},{"key":"8621_CR126","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jaad.2016.06.016","volume":"75","author":"KS Thomas","year":"2016","unstructured":"Thomas KS, Ormerod AD, Craig FE, Greenlaw N, Norrie J, Mitchell E, Mason JM, Johnston GA, Wahie S, Williams HC, UK Dermatology Clinical Trials Network\u2019s STOP GAP Team (2016) Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: a prospective cohort study. J Am Acad Dermatol 75:940\u2013949. doi:\n10.1016\/j.jaad.2016.06.016","journal-title":"J Am Acad Dermatol"},{"key":"8621_CR127","first-page":"525","volume":"25","author":"YJ Bhat","year":"2015","unstructured":"Bhat YJ, Hassan I, Sajad P, Akhtar S, Sheikh S (2015) Sweet\u2019s syndrome: an evidence-based report. J Coll Physicians Surg Pak 25:525\u2013527","journal-title":"J Coll Physicians Surg Pak"},{"issue":"3\u20134","key":"8621_CR128","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s10354-016-0472-z","volume":"167","author":"AA Chokoeva","year":"2017","unstructured":"Chokoeva AA, Cardoso JC, Wollina U, Tchernev G (2017) Pyoderma gangrenosum\u2014a novel approach? Wien Med Wochenschr 167(3\u20134):58\u201365. doi:\n10.1007\/s10354-016-0472-z","journal-title":"Wien Med Wochenschr"},{"key":"8621_CR129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/157488412803305821","volume":"7","author":"N Pazyar","year":"2012","unstructured":"Pazyar N, Feily A, Yaghoobi R (2012) An overview of interleukin-1 receptor antagonist, anakinra, in the treatment of cutaneous diseases. Curr Clin Pharmacol 7:271\u2013275","journal-title":"Curr Clin Pharmacol"},{"key":"8621_CR130","doi-asserted-by":"publisher","first-page":"e27742","DOI":"10.4161\/rdis.27742","volume":"2","author":"JR Lukens","year":"2014","unstructured":"Lukens JR, Kanneganti TD (2014) SHP-1 and IL-1\u03b1 conspire to provoke neutrophilic dermatoses. Rare Dis 2:e27742. doi:\n10.4161\/rdis.27742","journal-title":"Rare Dis"},{"key":"8621_CR131","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/j.1365-2133.2009.09404.x","volume":"161","author":"M Brenner","year":"2009","unstructured":"Brenner M, Ruzicka T, Plewig G, Thomas P, Herzer P (2009) Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra. Br J Dermatol 161:1199\u20131201. doi:\n10.1111\/j.1365-2133.2009.09404.x","journal-title":"Br J Dermatol"},{"key":"8621_CR132","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/rheumatology\/keh479","volume":"44","author":"MP Dierselhuis","year":"2005","unstructured":"Dierselhuis MP, Frenkel J, Wulffraat NM, Boelens JJ (2005) Anakinra for flares of pyogenic arthritis in PAPA syndrome. Rheumatology (Oxford) 44:406\u2013408. doi:\n10.1093\/rheumatology\/keh479","journal-title":"Rheumatology (Oxford)"},{"key":"8621_CR133","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.smim.2013.10.008","volume":"25","author":"CA Dinarello","year":"2013","unstructured":"Dinarello CA, van der Meer JW (2013) Treating inflammation by blocking interleukin-1 in humans. Semin Immunol 25:469\u2013484. doi:\n10.1016\/j.smim.2013.10.008","journal-title":"Semin Immunol"},{"key":"8621_CR134","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1684\/ejd.2013.2018","volume":"23","author":"T Jaeger","year":"2013","unstructured":"Jaeger T, Andres C, Grosber M, Zirbs M, Hein R, Ring J, Traidl-Hoffmann C (2013) Pyoderma gangrenosum and concomitant hidradenitis suppurativa\u2014rapid response to canakinumab (anti-IL-1\u03b2). Eur J Dermatol 23:408\u2013410. doi:\n10.1684\/ejd.2013.2018","journal-title":"Eur J Dermatol"},{"key":"8621_CR135","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/2013.jamadermatol.717","volume":"149","author":"A Geusau","year":"2013","unstructured":"Geusau A, Mothes-Luksch N, Nahavandi H, Pickl WF, Wise CA, Pourpak Z, Ponweiser E, Eckhart L, Sunder-Plassmann R (2013) Identification of a homozygous PSTPIP1 mutation in a patient with a PAPA-like syndrome responding to canakinumab treatment. JAMA Dermatol 149:209\u2013215. doi:\n10.1001\/2013.jamadermatol.717","journal-title":"JAMA Dermatol"},{"key":"8621_CR136","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1111\/bjd.14037","volume":"173","author":"AG Kolios","year":"2015","unstructured":"Kolios AG, Maul JT, Meier B, Kerl K, Traidl-Hoffmann C, Hertl M, Zillikens D, R\u00f6cken M, Ring J, Facchiano A, Mondino C, Yawalkar N, Contassot E, Navarini AA, French LE (2015) Canakinumab in adults with steroid-refractory pyoderma gangrenosum. Br J Dermatol 173:1216\u20131223. doi:\n10.1111\/bjd.14037","journal-title":"Br J Dermatol"},{"key":"8621_CR137","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jaci.2016.07.041","volume":"139","author":"K Krause","year":"2017","unstructured":"Krause K, Tsianakas A, Wagner N, Fischer J, Weller K, Metz M, Church MK, Maurer M (2017) Efficacy and safety of canakinumab in Schnitzler syndrome: a multicenter randomized placebo-controlled study. J Allergy Clin Immunol 139:1311\u20131320. doi:\n10.1016\/j.jaci.2016.07.041","journal-title":"J Allergy Clin Immunol"},{"key":"8621_CR138","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1525-1470.2005.22320.x","volume":"22","author":"DS Stichweh","year":"2005","unstructured":"Stichweh DS, Punaro M, Pascual V (2005) Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome. Pediatr Dermatol 22:262\u2013265. doi:\n10.1111\/j.1525-1470.2005.22320.x","journal-title":"Pediatr Dermatol"},{"key":"8621_CR139","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/RHU.0b013e3181e969b9","volume":"16","author":"ND Tofteland","year":"2010","unstructured":"Tofteland ND, Shaver TS (2010) Clinical efficacy of etanercept for treatment of PAPA syndrome. J Clin Rheumatol 16:244\u2013245. doi:\n10.1097\/RHU.0b013e3181e969b9","journal-title":"J Clin Rheumatol"},{"key":"8621_CR140","first-page":"452","volume":"30","author":"H Lee","year":"2012","unstructured":"Lee H, Park SH, Kim SK, Choe JY, Park JS (2012) Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) with E250K mutation in CD2BP1 gene treated with the tumor necrosis factor inhibitor adalimumab. Clin Exp Rheumatol 30:452","journal-title":"Clin Exp Rheumatol"},{"key":"8621_CR141","doi-asserted-by":"publisher","unstructured":"Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CE, Papp K, et al (2014) ERASURE Study Group.; FIXTURE Study Group. Secukinumab in plaque psoriasis-results of two phase 3 trials. N Engl J Med 371:326\u2013338. doi: \n10.1056\/NEJMoa1314258","DOI":"10.1056\/NEJMoa1314258"},{"key":"8621_CR142","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/j.cell.2016.11.044","volume":"167","author":"PR Burkett","year":"2016","unstructured":"Burkett PR, Kuchroo VK (2016) IL-17 blockade in psoriasis. Cell 167:1669. doi:\n10.1016\/j.cell.2016.11.044","journal-title":"Cell"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-017-8621-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-017-8621-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-017-8621-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T23:50:23Z","timestamp":1517615423000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-017-8621-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,7]]},"references-count":142,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["8621"],"URL":"https:\/\/doi.org\/10.1007\/s12016-017-8621-8","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,7]]}}}